Novavax shares jump as FDA panel backs Covid vaccine
Shares of Novavax surged nearly 20% today after advisers to the Food and Drug Administration overwhelmingly backed the use of its Covid-19 vaccine, bringing the shot a step closer to a US launch.
Business
• 08 Jun 22
